Pineapple, Inc. (PNPL)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.47 Million USD | 81.19% |
| 2022 | -7.85 Million USD | -611.1% |
| 2021 | -1.1 Million USD | 3.83% |
| 2020 | -1.14 Million USD | 1.68% |
| 2019 | -1.16 Million USD | 14.41% |
| 2018 | -1.36 Million USD | -24.11% |
| 2017 | -1.09 Million USD | 87.21% |
| 2016 | -8.59 Million USD | -623.58% |
| 2015 | -1.18 Million USD | -98909.0% |
| 2014 | -1200.00 USD | 59.81% |
| 2013 | -2986.00 USD | -30.62% |
| 2012 | -2286.00 USD | -286.15% |
| 2011 | -592.00 USD | 0.0% |
| 2010 | - USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -466.09 Thousand USD | -2.66% |
| 2023 Q2 | -439.58 Thousand USD | -551.05% |
| 2023 Q3 | -516.51 Thousand USD | -17.5% |
| 2023 FY | -1.47 Million USD | 81.19% |
| 2023 Q4 | -454.02 Thousand USD | 12.1% |
| 2023 Q1 | -67.51 Thousand USD | -104.82% |
| 2022 Q2 | 137.48 Thousand USD | -63.36% |
| 2022 Q4 | 1.4 Million USD | 114.34% |
| 2022 FY | -7.85 Million USD | -611.1% |
| 2022 Q1 | 375.21 Thousand USD | 171.97% |
| 2022 Q3 | -9.76 Million USD | -7205.64% |
| 2021 Q3 | -356.39 Thousand USD | 25.28% |
| 2021 Q2 | -476.95 Thousand USD | -16.49% |
| 2021 Q4 | 137.96 Thousand USD | 138.71% |
| 2021 Q1 | -409.43 Thousand USD | 65.96% |
| 2021 FY | -1.1 Million USD | 3.83% |
| 2020 Q2 | -272.28 Million USD | 1.61% |
| 2020 FY | -1.14 Million USD | 1.68% |
| 2020 Q4 | -1.2 Million USD | 99.5% |
| 2020 Q3 | -238.22 Million USD | 12.51% |
| 2020 Q1 | -276.75 Million USD | 24.06% |
| 2019 Q4 | -364.4 Million USD | 0.0% |
| 2019 FY | -1.16 Million USD | 14.41% |
| 2018 FY | -1.36 Million USD | -24.11% |
| 2018 Q4 | -770.37 Thousand USD | 0.0% |
| 2017 FY | -1.09 Million USD | 87.21% |
| 2016 FY | -8.59 Million USD | -623.58% |
| 2015 Q1 | -541.00 USD | -72.29% |
| 2015 FY | -1.18 Million USD | -98909.0% |
| 2015 Q3 | -594.12 Thousand USD | -544964.22% |
| 2015 Q2 | -109.00 USD | 79.85% |
| 2014 Q2 | 86.00 USD | 110.15% |
| 2014 Q1 | -847.00 USD | 41.14% |
| 2014 FY | -1200.00 USD | 59.81% |
| 2014 Q4 | -314.00 USD | -151.2% |
| 2014 Q3 | -125.00 USD | -245.35% |
| 2013 Q1 | -847.00 USD | 0.0% |
| 2013 FY | -2986.00 USD | -30.62% |
| 2013 Q4 | -1439.00 USD | -50.68% |
| 2013 Q3 | -955.00 USD | -474.51% |
| 2013 Q2 | 255.00 USD | 130.11% |
| 2012 FY | -2286.00 USD | -286.15% |
| 2011 FY | -592.00 USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -3703.18 USD | -39801.814% |
| Allstar Health Brands, Inc. | -499.34 Thousand USD | -195.916% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 69.18 Million USD | 102.136% |
| Café Serendipity Holdings, Inc. | -750.15 Thousand USD | -96.977% |
| Decision Diagnostics Corp. | - USD | Infinity% |
| Health Advance Inc. | -49.02 Thousand USD | -2914.23% |
| HealthWarehouse.com, Inc. | -1.77 Million USD | 16.686% |
| LIGAND PHARMACEUTICAL INC | 52.15 Million USD | 102.833% |
| MedGen, Inc. | -15.54 USD | -9508497.169% |
| Omni Health, Inc. | 1.26 Million USD | 216.75% |
| Oxford Investments Holdings Inc. | -299.1 Thousand USD | -394.022% |
| ScripsAmerica, Inc. | -4.73 Million USD | 68.767% |